Blue Horseshoe Stocks

Blue Horseshoe Stocks: AMPG Update

Amplitech Group, Inc. AMPG – Updates

We first began covering AMPG at the beginning of April. In the five weeks since then, the stock has made some solid progress on the chart, trading up from a low of .043, to its new high, just reached this week at .055. That’s a solid 28% increase, with no significant pullbacks along the way.

Our interest in the potential of AMPG was obviously justified, but we’re just getting started and we’re as excited as ever. As we’ve mentioned before, Amplitech is in the business of high-end signal amplification technologies with a veritable myriad of applications in a world which is becoming increasingly reliant upon wireless technology.

The transition has already begun- 5G is soon to be the gold standard in wireless communications, and AMPG is among the best OTC stocks we’ve run across to invest in the domestic 5G phenomenon. All of AMPG’s technology is Made in the USA.

With no toxic or long-term debt, and a float of just over 22M shares, AMPG is attractive to traders and longer-term investors alike. With a market cap of just $2.65M along with a pipeline of military-grade RF products and more in development, it’s also safe to say that AMPG is grossly undervalued. The company isn’t just resting on its laurels, either. AMPG recently added a highly experienced investment professional to act as an independent member of the board, chairing several special committees, and free up the CEO to more closely manage the company’s extreme growth potential and execution of strategy.

CEO Fawad Maqbool stated: “I am thrilled to have a seasoned investment banker, entrepreneur and investor such as Wayne committing his time and energy to our emerging company. He should be invaluable to me in this next phase of our growth as it will allow me to better focus on our products, our customers and the opportunities that are emerging in the industries that we currently serve (custom and standard amplifiers for radar, missile systems, drones and many microwave communications systems), and will seek to serve in the future (innovative power and cryogenic amplifiers for 4G/5G wireless base stations, Wi-Fi for airlines, military jamming, quantum computing, internet of things, cyber security, life sciences and others).” (>>View Full PR)
_____

AMPG CHART:

_____

For more information visit:
AmpliTechInc.com

OR CONTACT: Fawad Maqbool, CEO at (631) 521-7831
Twitter: twitter.com/AmpliTechAMPG
Instagram: instagram.com/amplitechampg
Facebook: facebook.com/AmpliTechInc

Blue Horseshoe Stocks: SUNW Update & More

Sunworks, Inc. SUNW – Update

We brought SUNW to our readers in our report on Friday morning, and despite having already spent nearly the whole of April in a steady uptrend, the stock is still making headway here in the month of May.

From the low of 1.264 that was registered on the morning of our initial alert, the stock made its way to 1.97 yesterday, which represents a three-day upswing and total possible gains of 56% for our readers.The stock is now well into blue sky breakout territory, so there’s no telling how much higher it could go, bu we’ll certainly continue to keep an eye peeled.

Fresh Options Idea:

Electronic Arts, Inc. EA – With a solid beat on both earnings and revs, we’re looking to EA this morning on the heels of its quarterly financials drop. Expectations on future guidance from the company have also been exceeded.

We’re going to be focusing on the EA Weekly $98.50-100 Calls in response to the present conditions and activity we are observing here in the premarket.

Extended Watchlist:
AMPG, GNMX, PAGP, CVRS, FTFT, IDEX, TROV, HUSA

Blue Horseshoe Stocks: CHMJF Special Report

Chemistree Technology, Inc. – Special Report
(OTCMKTS:CHMJF) (CSE:CHM)

Our primary order of business today is to profile a stock that we’ve never mentioned on our websites before, however, one that is actively involved in a market space that we’ve covered extensively. Cannabis has been at or near the top of our interests ever since our coverage of the legendary Green Rush of 2012, and continuing through to present-day.

Chemistree Technology Inc. is self-billed as an investment company which provides turn-key solutions for the regulated cannabis industry through the development of vertically integrated cannabis assets, including licensed cultivation, processing, distribution and retail facilities.

Perhaps the most impressive aspect of CHMJF is the rapidity with which the company has gone about executing its corporate strategy. In just the past year, it has acquired and/or developed cannabis assets in California and Washington State, with even more currently under construction.

In Washington State last May, the company acquired the Sugarleaf cannabis brand, along with the growing and processing facility that produces it, and all associated licenses. Sugarleaf branded cannabis is currently available in more than twenty retail locations, with plans to expand that to more than a hundred outlets in the next year. The company expects to generate roughly $2.7M in 2019 revenue for this facility alone.

In California, Chemistree has arranged a strategic collaboration with a Humboldt county cannabis-to-CBD processing company. CHMJF provided a $450K loan in exchange for immediate access to the California markets and the ability to purchase cannabis for processing at the facility, which it expects to bring in as much as $1.5M in revenue in 2019 alone.

Additionally, the company purchased 9.55 acres of land in cannabis-hotspot, Desert Hot Springs, California last year. It has completed the continuous-use permit, and is currently finalizing plans for two 64,000 square foot greenhouses and a 40,000 square foot manufacturing and distribution facility, subject to the approval of the city planner’s office.

These highlights only scratch the surface of what CHMJF has accomplished in just the last year, and hint at a promising finish to 2019, along with a bright future beyond. CHMJF has quickly become an area of special interest for us in the cannabis space.
_____

IMPORTANT! All readers should take the time to
>>VIEW this IN-DEPTH OVERVIEW of CHMJF<<
_____

MOST RECENT DEVELOPMENT: VANCOUVER, April 29, 2019 /PRNewswire/ – Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), is pleased to announce that the Company has entered into a funding agreement with The Physician’s Choice CBD LLC of Phoenix, Arizona.

The Physician’s Choice CBD (“PCCBD”) is dedicated to research, development, and utilization of the highest quality of hemp-derived cannabidiol (CBD) combined with well-studied and effective supplements specific to help regulate and support various symptoms. The integration of extensive physician clinical experience combined with exhaustive expertise in the cannabis industry has led to the creation of The Physician’s Choice CBD. (>>View Full PR)

_____

CHMJF CHART:

_____

For More Information on CHMJF, visit:
chemistree.ca/
____

Don’t forget to check out THIS REPORT on CHMJF!

Blue Horseshoe Stocks: SPY, MAXR Recaps & More

Maxar Technologies, Inc. MAXR – Review

Despite what appears to be a significant downturn looming this morning, the markets as a whole posted a solid bullish session on Friday, and that helped one stock we’ve been tracking in recent weeks to record a new high for us.

We tagged MAXR for observation in mid-March, and before the end of the month, it had consolidated down to a low of 3.83. The month of April brought a fairly steady uptrend, and Friday’s strong performance kicked it up another notch. The stock hit a new high of 6.66, marking a move of 74% in just over six weeks. The stock filled almost the entire topside gap that was on the chart, and the RSI has just cracked into the Power Zone, so we’ll want to continue to keep an eye on its activity.

Sysco Corp. SYY – Options Idea

Despite continued China trade tensions throwing a wrench into the markets to start the week today, we are going to be looking a little further ahead with an options idea relating to the imminent golden cross on the SYY chart, combined with the company’s earnings beat posted this morning in the premarket.

The food wholesaler has a chance to break a double top, and we’re going to be ready with an options idea in the event that it manages to do so. Our highlighted targets are going to be the SYY 06/14 $69.50-71 Calls.
_____

Friday SPY Update: We signaled interest in the SPDR S&P500 ETF (SPY) Weekly $292.50 Calls on Friday morning, and those contracts traded up from a low of .53 to 1.76, which represented a single-session move of 232%

Special Note: Our extended watchlist today contains more penny stocks than usual. The OTC tends to heat up when uncertainty strikes the larger markets. We’ll have an eye peeled for interesting activity on that front.

Extended Watchlist:
ZIXI, NAFS, TMGI, TTCM, DAVC, SNYR, CTRV, RMTI, HEB

Blue Horseshoe Stocks: Earnings Related Options Ideas

Earnings Related Options Ideas

As our regular readers are well aware, a majority of our focus in recent years has been shifted from straight stock trading ideas to options. More specifically, short-term options in companies that have just reported their quarterly earnings.

We are the absolute best newsletter for options daytrading in existence, routinely providing ideas with multi-bag gain potential each and every week. Our record, which anyone can view at any time in our archives, speaks for itself.

After a huge number of reporting companies just released their quarterlies and several high impact economic reports came back positive this morning, we’re going to revisit some ideas in a few chains that have been good to us in the past:

Shake Shack, Inc. SHAK Weekly $67.50 Calls
Weight Watchers International, Inc. WW Weekly $22.50 Calls
SPDR S&P500 ETF (SPY) Weekly $292.50 Calls
____

Bonus Idea:

Biogen, Inc. BIIB has been largely trading sideways since its huge flop on its alzheimer’s drug back in March caused a massive cratering of the stock. We look for large gaps on charts like this, along with signs that a stock has reached its lowest likely trading value. The latter signal, we can infer from the huge blocks of insider buying at current levels which have been reported over the past week. Two Form-4’s amounting to a total of roughly $20M in insider buys suggest that the current base is solid. We’ll look to take advantage of a longer-term idea and track the BIIB 07/19 $240-250 Calls.

ARCA Biopharma, Inc. ABIO

Occasionally we do still provide straight stock ideas as well, when a solid bottom or news play catches our attention. We put ABIO on bottom watch at the end of March when it was trading in the upper-$6 to $7 range. The stock was under steady consolidation for the whole of April, and reached as low as 5.01 just this week before launching into a huge two day uptrend.

Yesterday it reached a new high of 20.45, which marks an overall rise of 308% We also re-tagged it in our premarket report yesterday, and for those that only put it on their radars following that alert, yesterday’s intraday move alone was fairly impressive. It ran from 12.03 up to the previously mentioned high, which marks a one day upswing of 70%

Extended Watchlist:
TROV, SUNW, UXIN, CBLK, BRKR, CBLK, RPD, ADOM, VTVT, ZIXI, IDEX